Jose Betancourt, MD
Cardiovascular Disease · Keene, NHNPI 1992748149
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Boston Scientific at 39.8% of the total. Reporting peaked in 2019 at $7,214 and has fallen 99.8% since, to $13 in 2024.
Across 58 payments — averaging $141.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$2K
- Biotronik Inc.$1K
- Baylis Medical Company Inc$352
- Heartflow, Inc.$252
- Biosense Webster, Inc.$170
- plus $283 from 6 others
What the payments were for
- Travel & lodging$4,53555%
- Food & beverage$3,25240%
- Education$4345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $3,271 |
| Medtronic(2 entities) | 21 | $2,495 |
| Biotronik Inc. | 12 | $1,397 |
| Baylis Medical Company Inc | 1 | $352 |
| Heartflow, Inc. | 1 | $252 |
| Biosense Webster, Inc. | 3 | $170 |
| Cook Medical LLC | 1 | $100 |
| Cardiva Medical, Inc. | 1 | $63 |
| Abbott | 1 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $31 |
| Alk-abello, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,602
- Watchman$1,264
- NRG needle$352
- WATCHMAN Access System$145
- Carto 3 System$118
- Micra$115
- Cook Medical Evolution$100
How this compares
$8,221 in reported general payments places this provider in the 85th percentile of 112 cardiovascular disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 116 | $73,630 |
| EntrestoSacubitril/Valsartan | 26 | $18,521 |
| XareltoRivaroxaban | 13 | $7,661 |
| Rosuvastatin Calcium | 52 | $2,520 |
| Atorvastatin Calcium | 111 | $1,804 |
| Metoprolol Succinate | 168 | $1,593 |
| Ranolazine ErRanolazine | 15 | $1,313 |
| PaceroneAmiodarone Hcl | 24 | $854 |
| Losartan Potassium | 102 | $835 |
| ClopidogrelClopidogrel Bisulfate | 27 | $831 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $444 |
| Nebivolol Hcl | 11 | $440 |
| Carvedilol | 84 | $404 |
| Spironolactone | 33 | $272 |
| Nitroglycerin | 18 | $255 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Keene
- Amr El MeligyKeene$5K
- Alan SteljesKeene$4K
- Peter ChienKeene$2K
- Olivia HungKeene$1K
- Fahad GilaniManchester$418K
- Stephan HeoManchester$116K
- Robert CapodilupoManchester$85K
- Kevin KwakuLebanon$79K
- Michael YoungLebanon$53K
- Jeanney LewManchester$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.